Neuroprotective therapy for HIV dementia.

Jadwiga Turchan, Ned Sacktor, Valerie Wojna, Katherine Conant, Avi Nath

Research output: Contribution to journalArticle

Abstract

Despite the development and use of effective antiretroviral therapy, HIV dementia persists and has important socio-economic consequences. Significant progress has been made in our current understanding of the neuropathogenesis of HIV infection, and it is clear that adjunctive neuroprotective therapy in addition to antiretroviral therapy are necessary for prevention and treatment of this entity. In this manuscript, we discuss the rationale and the pathophysiological mechanisms that support the development of neuroprotective therapy for HIV dementia. We review all the placebo controlled clinical trials conducted to date with neuromodulatory/neuroprotective therapy in patients with HIV dementia and discuss their outcomes. We also provide a thorough review of potential new treatments for HIV dementia based on the experimental literature. We hope that this manuscript will serve as an important guide for future approaches for clinical trials and drug development for patients with HIV dementia.

Original languageEnglish (US)
Pages (from-to)373-383
Number of pages11
JournalCurrent HIV Research
Volume1
Issue number4
StatePublished - Oct 2003

Fingerprint

AIDS Dementia Complex
Therapeutics
Controlled Clinical Trials
HIV Infections
Placebos
Economics
Clinical Trials

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Turchan, J., Sacktor, N., Wojna, V., Conant, K., & Nath, A. (2003). Neuroprotective therapy for HIV dementia. Current HIV Research, 1(4), 373-383.

Neuroprotective therapy for HIV dementia. / Turchan, Jadwiga; Sacktor, Ned; Wojna, Valerie; Conant, Katherine; Nath, Avi.

In: Current HIV Research, Vol. 1, No. 4, 10.2003, p. 373-383.

Research output: Contribution to journalArticle

Turchan, J, Sacktor, N, Wojna, V, Conant, K & Nath, A 2003, 'Neuroprotective therapy for HIV dementia.', Current HIV Research, vol. 1, no. 4, pp. 373-383.
Turchan J, Sacktor N, Wojna V, Conant K, Nath A. Neuroprotective therapy for HIV dementia. Current HIV Research. 2003 Oct;1(4):373-383.
Turchan, Jadwiga ; Sacktor, Ned ; Wojna, Valerie ; Conant, Katherine ; Nath, Avi. / Neuroprotective therapy for HIV dementia. In: Current HIV Research. 2003 ; Vol. 1, No. 4. pp. 373-383.
@article{087aa032e8f4496491b382fbb82c7d42,
title = "Neuroprotective therapy for HIV dementia.",
abstract = "Despite the development and use of effective antiretroviral therapy, HIV dementia persists and has important socio-economic consequences. Significant progress has been made in our current understanding of the neuropathogenesis of HIV infection, and it is clear that adjunctive neuroprotective therapy in addition to antiretroviral therapy are necessary for prevention and treatment of this entity. In this manuscript, we discuss the rationale and the pathophysiological mechanisms that support the development of neuroprotective therapy for HIV dementia. We review all the placebo controlled clinical trials conducted to date with neuromodulatory/neuroprotective therapy in patients with HIV dementia and discuss their outcomes. We also provide a thorough review of potential new treatments for HIV dementia based on the experimental literature. We hope that this manuscript will serve as an important guide for future approaches for clinical trials and drug development for patients with HIV dementia.",
author = "Jadwiga Turchan and Ned Sacktor and Valerie Wojna and Katherine Conant and Avi Nath",
year = "2003",
month = "10",
language = "English (US)",
volume = "1",
pages = "373--383",
journal = "Current HIV Research",
issn = "1570-162X",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Neuroprotective therapy for HIV dementia.

AU - Turchan, Jadwiga

AU - Sacktor, Ned

AU - Wojna, Valerie

AU - Conant, Katherine

AU - Nath, Avi

PY - 2003/10

Y1 - 2003/10

N2 - Despite the development and use of effective antiretroviral therapy, HIV dementia persists and has important socio-economic consequences. Significant progress has been made in our current understanding of the neuropathogenesis of HIV infection, and it is clear that adjunctive neuroprotective therapy in addition to antiretroviral therapy are necessary for prevention and treatment of this entity. In this manuscript, we discuss the rationale and the pathophysiological mechanisms that support the development of neuroprotective therapy for HIV dementia. We review all the placebo controlled clinical trials conducted to date with neuromodulatory/neuroprotective therapy in patients with HIV dementia and discuss their outcomes. We also provide a thorough review of potential new treatments for HIV dementia based on the experimental literature. We hope that this manuscript will serve as an important guide for future approaches for clinical trials and drug development for patients with HIV dementia.

AB - Despite the development and use of effective antiretroviral therapy, HIV dementia persists and has important socio-economic consequences. Significant progress has been made in our current understanding of the neuropathogenesis of HIV infection, and it is clear that adjunctive neuroprotective therapy in addition to antiretroviral therapy are necessary for prevention and treatment of this entity. In this manuscript, we discuss the rationale and the pathophysiological mechanisms that support the development of neuroprotective therapy for HIV dementia. We review all the placebo controlled clinical trials conducted to date with neuromodulatory/neuroprotective therapy in patients with HIV dementia and discuss their outcomes. We also provide a thorough review of potential new treatments for HIV dementia based on the experimental literature. We hope that this manuscript will serve as an important guide for future approaches for clinical trials and drug development for patients with HIV dementia.

UR - http://www.scopus.com/inward/record.url?scp=2142702974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142702974&partnerID=8YFLogxK

M3 - Article

C2 - 15049424

AN - SCOPUS:2142702974

VL - 1

SP - 373

EP - 383

JO - Current HIV Research

JF - Current HIV Research

SN - 1570-162X

IS - 4

ER -